Lupin Ltd - Company Profile
Powered by
All the data and insights you need on Lupin Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Lupin Ltd Strategy Report
- Understand Lupin Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lupin Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
07 Sep 2022 | Multicare Pharma and DKSH Enter into Licensing Agreement with Alvotech | Licensing Agreement |
DKSH Holding Ltd
Multicare Pharmaceuticals Philippines Inc
|
Alvotech Holdings SA
|
01 Sep 2022 | Juno Pharmaceuticals Enters Manufacturing and Packaging Agreement with Lupin for Sugammadex | Contract Service Agreement |
Juno Pharmaceuticals NZ Ltd
|
Lupin Ltd |
25 Aug 2022 | I’rom Pharma Enters into Licensing Agreement with Lupin | Licensing Agreement |
I’rom Pharmaceutical Co., Ltd.
|
Lupin Ltd |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer